<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; TI Pharma</title>
	<atom:link href="http://blog.taragana.com/pr/t/ti-pharma/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.taragana.com/pr</link>
	<description></description>
	<pubDate>Tue, 26 Jan 2010 05:00:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Veerman Committee Argues for Continuation of TI Pharma</title>
		<link>http://blog.taragana.com/pr/veerman-committee-argues-for-continuation-of-ti-pharma-12161/</link>
		<comments>http://blog.taragana.com/pr/veerman-committee-argues-for-continuation-of-ti-pharma-12161/#comments</comments>
		<pubDate>Tue, 26 Jan 2010 05:00:00 +0000</pubDate>
		<dc:creator>Ti Pharma</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Leiden]]></category>

		<category><![CDATA[Netherlands]]></category>

		<category><![CDATA[The Netherlands]]></category>

		<category><![CDATA[TI Pharma]]></category>

		<category><![CDATA[Translation]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/veerman-committee-argues-for-continuation-of-ti-pharma-12161/</guid>
		<description><![CDATA[LEIDEN, The Netherlands, January 26  - Top Institute Pharma (TI Pharma) enables unique public-private
collaborations that are extremely valuable for pharmaceutical research in the
Netherlands. This can be read in the Midterm Review (MTR) of the Top
Institute, which was published today. In the report, an independent committee
chaired by Cees Veerman concludes that TI Pharma is well [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/veerman-committee-argues-for-continuation-of-ti-pharma-12161/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Dutch Top Institute Pharma Attracts International Interest</title>
		<link>http://blog.taragana.com/pr/dutch-top-institute-pharma-attracts-international-interest-5774/</link>
		<comments>http://blog.taragana.com/pr/dutch-top-institute-pharma-attracts-international-interest-5774/#comments</comments>
		<pubDate>Thu, 10 Sep 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Health]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[denmark]]></category>

		<category><![CDATA[Leiden]]></category>

		<category><![CDATA[Netherlands]]></category>

		<category><![CDATA[TI Pharma]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/dutch-top-institute-pharma-attracts-international-interest-5774/</guid>
		<description><![CDATA[LEIDEN, The Netherlands - The Danish Council for Strategic Research is visiting the Dutch Top Institute Pharma (TI Pharma) on Thursday, September 10. The purpose of their visit is to learn about the unique Dutch approach on public-private cooperation and the concrete results that are being booked by this institute. In the past, in the [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/dutch-top-institute-pharma-attracts-international-interest-5774/feed/</wfw:commentRss>
		</item>
		<item>
		<title>New Consortium to Develop Drugs for Neglected Tropical Diseases</title>
		<link>http://blog.taragana.com/pr/new-consortium-to-develop-drugs-for-neglected-tropical-diseases-4929/</link>
		<comments>http://blog.taragana.com/pr/new-consortium-to-develop-drugs-for-neglected-tropical-diseases-4929/#comments</comments>
		<pubDate>Mon, 17 Aug 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Africa]]></category>

		<category><![CDATA[kenya]]></category>

		<category><![CDATA[Leiden]]></category>

		<category><![CDATA[Netherlands]]></category>

		<category><![CDATA[Switzerland]]></category>

		<category><![CDATA[TI Pharma]]></category>

		<category><![CDATA[Uganda]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/new-consortium-to-develop-drugs-for-neglected-tropical-diseases-4929/</guid>
		<description><![CDATA[LEIDEN, The Netherlands - A new consortium has been formed to boost drug development for the treatment of two deadly diseases, African sleeping sickness and Leishmaniasis, which affect millions of people worldwide. A total budget of nearly 3.6 million euros has been allocated over the next 4 years, to develop effective drugs for these diseases. [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/new-consortium-to-develop-drugs-for-neglected-tropical-diseases-4929/feed/</wfw:commentRss>
		</item>
		<item>
		<title>New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects</title>
		<link>http://blog.taragana.com/pr/new-small-and-medium-sized-enterprises-join-ti-pharma-by-signing-two-new-projects-3838/</link>
		<comments>http://blog.taragana.com/pr/new-small-and-medium-sized-enterprises-join-ti-pharma-by-signing-two-new-projects-3838/#comments</comments>
		<pubDate>Mon, 06 Jul 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Budget]]></category>

		<category><![CDATA[Leiden]]></category>

		<category><![CDATA[Netherlands]]></category>

		<category><![CDATA[TI Pharma]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/new-small-and-medium-sized-enterprises-join-ti-pharma-by-signing-two-new-projects-3838/</guid>
		<description><![CDATA[LEIDEN, The Netherlands - Three new small and medium sized enterprises (SMEs) - Syncom, Synvolux Therapeutics and InteRNA Technologies - have joined public-private partnership TI Pharma by participating in two new projects. These projects, focusing on cancer and inflammatory diseases, have a total budget of nearly 6 million euros.

The new consortium, formed by Syncom, Synvolux [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/new-small-and-medium-sized-enterprises-join-ti-pharma-by-signing-two-new-projects-3838/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Dutch Consortium Builds Registry Framework for Care of Rare Diseases</title>
		<link>http://blog.taragana.com/pr/dutch-consortium-builds-registry-framework-for-care-of-rare-diseases-922/</link>
		<comments>http://blog.taragana.com/pr/dutch-consortium-builds-registry-framework-for-care-of-rare-diseases-922/#comments</comments>
		<pubDate>Mon, 06 Apr 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[College]]></category>

		<category><![CDATA[Europe]]></category>

		<category><![CDATA[Leiden]]></category>

		<category><![CDATA[Netherlands]]></category>

		<category><![CDATA[TI Pharma]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/dutch-consortium-builds-registry-framework-for-care-of-rare-diseases-922/</guid>
		<description><![CDATA[LEIDEN, The Netherlands - The Dutch Orphan Disease Registry Consortium is set up in order to build a disease registry framework to collect information on rare diseases, encourage drug development and optimize patient care. The consortium focuses on inborn errors of metabolism as target group of diseases.

The number of distinct rare (orphan) diseases is estimated [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/dutch-consortium-builds-registry-framework-for-care-of-rare-diseases-922/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

